Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lisata Therapeutics (LSTA) Long-Term Debt Issuances (2016 - 2017)

Lisata Therapeutics' Long-Term Debt Issuances history spans 8 years, with the latest figure at $2.0 for Q4 2017.

  • For Q4 2017, Long-Term Debt Issuances fell 100.0% year-over-year to $2.0; the TTM value through Sep 2018 reached $2.0, down 100.0%, while the annual FY2017 figure was $401000.0, 50.09% down from the prior year.
  • Long-Term Debt Issuances reached $2.0 in Q4 2017 per LSTA's latest filing, down from $400998.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $13.2 million in Q4 2014 to a low of -$221218.0 in Q3 2013.
  • Average Long-Term Debt Issuances over 5 years is $1.3 million, with a median of $391982.5 recorded in 2014.
  • Peak YoY movement for Long-Term Debt Issuances: surged 1169.78% in 2014, then plummeted 100.52% in 2015.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $1.0 million in 2013, then soared by 1169.78% to $13.2 million in 2014, then plummeted by 100.02% to -$2250.0 in 2015, then skyrocketed by 19428.13% to $434883.0 in 2016, then tumbled by 100.0% to $2.0 in 2017.
  • Per Business Quant, the three most recent readings for LSTA's Long-Term Debt Issuances are $2.0 (Q4 2017), $400998.0 (Q1 2017), and $434883.0 (Q4 2016).